Evidence map›Paper›PMID 18164807›Full record

ReviewCancer letters2008

Field defects in progression to gastrointestinal tract cancers.

Carol Bernstein, Harris Bernstein, Claire M Payne, Katerina Dvorak, Harinder Garewal

Abstract readReview
In one paragraph

Review in Cancer letters, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

39 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. The renin-angiotensin system mediates EGF receptor-vitamin d receptor cross-talk in colitis-associated colon cancer.Clinical cancer research : an official journal of the American Association for Cancer Research · 2014
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Carol BernsteinDepartment of Cell Biology and Anatomy, College of Medicine, University of Arizona, and Hematology/Oncology Southern Arizona Veterans Affairs Health Care System, Tucson, AZ 85723, USA. bernstein3@earthlink.net
Harris Bernstein
Claire M Payne
Katerina Dvorak
Harinder Garewal

Funding

SPORE in Gastrointestinal CancerP50CA095060 · NCI · UNIVERSITY OF ARIZONA · PI GERNER, EUGENE W · 2002 to 2012
$25.3M
Preventive of Bile Acid-Induced Colonic Oxidative DNA DamageR01CA119087 · NCI · UNIVERSITY OF ARIZONA · PI PAYNE, CLAIRE MARGARET · 2006 to 2010
$1.3M
Cytochrome C Oxidase I:A Biomarker for Colon Cancer RiskR21CA111513 · NCI · UNIVERSITY OF ARIZONA · PI PAYNE, CLAIRE MARGARET · 2005 to 2006
$256k
NCI NIH HHS 1 P50 CA95060NCI NIH HHS 5 R01 CA119087NCI NIH HHS P50 CA095060NCI NIH HHS R01 CA119087NCI NIH HHS R21 CA111513NCI NIH HHS R21CA111513-01A1
6 · The paper itself

Abstract

A field of defective tissue may represent a pre-malignant stage in progression to many cancers. However, field defects are often overlooked in studies of cancer progression through assuming tissue at some distance from the cancer is normal. We indicate, however, the generality of field defects in gastrointestinal cancers, including cancers of the oropharynx, esophagus, stomach, bile duct, pancreas, small intestine and colon/rectum. Common features of these field defects are reduced apoptosis competence, aberrant proliferation and genomic instability. These features are often associated with high bile acid exposure and may explain the association of dietary-related factors with cancer progression.

Indexed as

AdenocarcinomaAnimalsApoptosisBile Acids and SaltsBile Duct NeoplasmsCarcinoma, Squamous CellCell ProliferationCell Transformation, NeoplasticCholangiocarcinomaDisease ProgressionEsophageal NeoplasmsGastrointestinal NeoplasmsGene Expression Regulation, NeoplasticGenomic InstabilityHead and Neck NeoplasmsHumansBile Acids and Salts

Identifiers

PMID18164807
PMCPMC2744582

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.